Search research articles
Contact Us
Filters
Showing results (51-60 of 298) with videos related to
Page
of 30
Sort By:
Stem Cells and Cloning : Advances and Applications
|
November 8, 2013
Hepatic progenitors for liver disease: current position
Alice Conigliaro, David A Brenner, Tatiana Kisseleva
Plos One
|
July 30, 2015
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation
Tian Lan, Tatiana Kisseleva, David A Brenner
Methods in Molecular Biology (Clifton, N.J.)
|
May 29, 2023
Human Hepatic Stellate Cells: Isolation and Characterization
Xiao Liu, David A Brenner, Tatiana Kisseleva
Hepatology Communications
|
February 16, 2019
Combatting Fibrosis: Exosome-Based Therapies in the Regression of Liver Fibrosis
Li Chen, David A Brenner, Tatiana Kisseleva
Experimental Biology and Medicine (Maywood, N.J.)
|
August 25, 2005
Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils
Lela Stefanovic, David A Brenner, Branko Stefanovic
Journal of Gastroenterology and Hepatology
|
February 11, 2012
What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis
Keiko Iwaisako, David A Brenner, Tatiana Kisseleva
The Journal of Biological Chemistry
|
March 13, 2002
Inhibition of collagen alpha 1(I) expression by the 5' stem-loop as a molecular decoy
Branko Stefanovic, Bernd Schnabl, David A Brenner
Nature Clinical Practice. Gastroenterology & Hepatology
|
July 17, 2008
What is the potential role of antifibrotic agents for the treatment of liver disease?
Bernd Schnabl, David Scholten, David A Brenner
Current Opinion in Gastroenterology
|
May 25, 2010
Recent advances in liver stem cell therapy
Tatiana Kisseleva, Elia Gigante, David A Brenner
International Journal of Molecular Sciences
|
April 10, 2019
The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
Jacopo Baglieri, David A Brenner, Tatiana Kisseleva
Page
of 30
Search research articles
Search
Showing results (51-60 of 298) with videos related to
Sort By:
Page
of 30
Stem Cells and Cloning : Advances and Applications
|
November 8, 2013
Hepatic progenitors for liver disease: current position
Alice Conigliaro, David A Brenner, Tatiana Kisseleva
Plos One
|
July 30, 2015
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation
Tian Lan, Tatiana Kisseleva, David A Brenner
Methods in Molecular Biology (Clifton, N.J.)
|
May 29, 2023
Human Hepatic Stellate Cells: Isolation and Characterization
Xiao Liu, David A Brenner, Tatiana Kisseleva
Hepatology Communications
|
February 16, 2019
Combatting Fibrosis: Exosome-Based Therapies in the Regression of Liver Fibrosis
Li Chen, David A Brenner, Tatiana Kisseleva
Experimental Biology and Medicine (Maywood, N.J.)
|
August 25, 2005
Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils
Lela Stefanovic, David A Brenner, Branko Stefanovic
Journal of Gastroenterology and Hepatology
|
February 11, 2012
What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis
Keiko Iwaisako, David A Brenner, Tatiana Kisseleva
The Journal of Biological Chemistry
|
March 13, 2002
Inhibition of collagen alpha 1(I) expression by the 5' stem-loop as a molecular decoy
Branko Stefanovic, Bernd Schnabl, David A Brenner
Nature Clinical Practice. Gastroenterology & Hepatology
|
July 17, 2008
What is the potential role of antifibrotic agents for the treatment of liver disease?
Bernd Schnabl, David Scholten, David A Brenner
Current Opinion in Gastroenterology
|
May 25, 2010
Recent advances in liver stem cell therapy
Tatiana Kisseleva, Elia Gigante, David A Brenner
International Journal of Molecular Sciences
|
April 10, 2019
The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
Jacopo Baglieri, David A Brenner, Tatiana Kisseleva
Page
of 30